 Meridian Bioscience Inc. VIVO, 7.02 announced an agreement Thursday to be acquired by a consortium of South Korea-based SD Biosensor Inc. 137310, 2.08 and private equity firm SJL Partners LLC in a cash deal valued at 1.53 billion. Under terms of the deal, Meridian shareholders will receive 34.00 in cash for each Meridian share they own, representing a 1.3 premium to Wednesdays closing price of 33.55. 